About the RETAIN study: Improving RETention and viral load outcomes for people taking Antiretroviral therapy through early IdentificatioN of missed doses
Too few South Africans living with HIV achieve viral suppression. Although advances in antiretroviral therapy (ART) have reduced…
Africa REACH welcomes news that Zimbabwe becomes the first African country to approve injectable PrEP
*This article is based off a press release distributed by DTHF partner, Africa REACH. The Medicines Control…
The SOGI Universe: Which planet do you come from?
People whose sexual orientation and gender identity (SOGI) do not conform to the majority may experience hostility and…
PURPOSE 2 – Join this PrEP Trial
Are you a man or a transgender person who has sex with men? We want to talk to…
The Desmond Tutu Health Foundation condemns statements on HIV/AIDS by former President Thabo Mbeki
The Desmond Tutu Health Foundation (DTHF) would like to add our voice to the growing number of organisations…
About the SUSTAIN study: SUpporting Sustained HIV Treatment Adherence after INitiation
UNAIDS goals specify that country programs should achieve viral suppression in at least 90% of those who start…
Safe Spaces Network: How the DTHF Engages with the LGBTQI+ community
Men who have sex with men (MSM) and Transgender Men and Women have been historically marginalised within…
FASTPrEP Project Kicks Off in Cape Town
Adolescent girls and young women remain at disproportionately high risk of HIV infection in Sub-Saharan Africa. Pre-exposure prophylaxis…
ADVANCES IN ANTIRETROVIRAL THERAPY ADHERENCE MONITORING
South Africa has fallen short of the UNAIDS 90-90-90 goals for 2020, particularly in the second two measures:…